Treating Covid-19 could lead to increased antimicrobial resi
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The use of antibiotics in people with Covid-19 could result in increased resistance to the drugs' benefits among the wider population, a new study published in the Journal of Antimicrobial Chemotherapy

Patients hospitalised as a result of the virus are being given a combination of medications to prevent possible secondary bacterial infections.

Research suggests their increased use during the pandemic could be placing an additional burden on wastewater treatment works.

This could lead to raised levels of antibiotics within the UK's rivers or coastal waters, which may, in turn, result in an increase in antimicrobial resistance (AMR), where bacteria become resistant to the action of antibiotics.

This would be particularly acute in receiving waters from wastewater treatment works serving large hospitals, or emergency 'Nightingale' hospitals, where there is a concentration of Covid-19 patients.

The findings are based on reports that up to 95 per cent of Covid-19 inpatients are being prescribed antibiotics as part of their treatment, and concerns that such a large-scale drug administration could have wider environmental implications.

"It is clear that mass prescribing of antibiotics will lead to increased levels in the environment and we know this can select for resistant bacteria. Studies like this are essential so that we can plan how to guide antibiotic prescription in future pandemics," Mathew Upton, Professor of Medical Microbiology at the university and a co-author on the research said.

K●●●l P●●●l and 3 others like this3 shares